PLUS1
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Johnson and Johnson | NYSE:JNJ | NYSE | Common Stock |
| Price Change | % Change | Share Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|
| -0.52 | -0.31% | 166.58 | 5,895,359 | 21:03:04 |
| Bid Price | Offer Price | High Price | Low Price | Open Price | |
|---|---|---|---|---|---|
| 168.72 | 166.3165 | 167.20 | |||
| Industry Sector | Turnover (m) | Profit (m) | EPS - Basic | PE Ratio | Market Cap (m) |
|---|---|---|---|---|---|
| Healthcare | 82,584.00 | 19,324.66 | 5.51 | 25.1 | 438,538 |
| Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
|---|---|---|---|---|
| 21:06:03 | 10 | 166.62 | USD |
Johnson and Johnson (JNJ) Latest News (1)
Johnson and Johnson News
| Date | Time | Source | Headline |
|---|---|---|---|
| 19/1/2022 | 10:33 | DJN | Valneva Shares Suffer as Coronavirus Vaccine Seen Arriving Too Late |
| 06/1/2022 | 22:32 | DJN | J&J: Study Shows 'Real World Evidence' of Covid Vaccine's 'Durable.. |
| 30/12/2021 | 12:13 | DJN | Johnson & Johnson Booster Showed Efficacy in South Africa During Omicron.. |
| 29/12/2021 | 13:54 | DJN | J&J's Janssen Seeks FDA OK of Teclistamab in Multiple Myeloma |
| 17/12/2021 | 14:03 | DJN | Dyadic Shares Rise 7% Premarket on Deal With Janssen Biotech |
| 07/12/2021 | 12:31 | DJN | J&J's Janssen: Phase 2b RSV Vaccine Study Meets All Endpoints |
| 03/12/2021 | 14:04 | DJN | Johnson & Johnson's Janssen Says Psoriatic Arthritis Trial Meets Objective |
| 29/11/2021 | 18:06 | DJN | Biden Says Administration Working With Vaccine Manufacturers on Contingency.. |
| 23/11/2021 | 12:18 | DJN | J&J's Janssen Gets Europe OK for Twice-Yearly Schizophrenia Treatment |
| 12/11/2021 | 14:44 | DJN | AC Immune Sees Positive Data in Trial for Alzheimer's Disease Treatment |
Johnson and Johnson (JNJ) Share Charts1 Year Johnson and Johnson Chart |
|
1 Month Johnson and Johnson Chart |
Intraday Johnson and Johnson Chart |
